{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:23:16Z","timestamp":1773174196221,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ygyno.2011.07.097","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T04:18:01Z","timestamp":1313900281000},"page":"456-460","source":"Crossref","is-referenced-by-count":17,"title":["Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis"],"prefix":"10.1016","volume":"123","author":[{"given":"Agnieszka","family":"Vay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Seward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaad","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan R.","family":"Munkarah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2011.07.097_bb0005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2011.07.097_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2011.07.097_bb0015","first-page":"S60","article-title":"Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease and new agents","volume":"2","author":"Ozols","year":"2004","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2011.07.097_bb0020","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/IGC.0b013e3181c14007","article-title":"Consolidation therapy in ovarian cancer: a clinical update","volume":"19","author":"Sabbatini","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.07.097_bb0025","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403947","article-title":"Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients","volume":"19","author":"Rund","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ygyno.2011.07.097_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical\u2013cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ygyno.2011.07.097_bb0035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1525-1438.2007.01185.x","article-title":"Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel and carboplatin based chemotherapy in an ovarian cancer patient: a case report and literature review","volume":"18","author":"Yeasmin","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"22","key":"10.1016\/j.ygyno.2011.07.097_bb0040","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jnci\/85.22.1858","article-title":"Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer","volume":"85","author":"Colon-Otero","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.07.097_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2011.07.097_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2008.09.001","article-title":"Emerging treatment strategies for acute myeloid leukemia in the elderly","volume":"35","author":"Kuendgen","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"5suppl. 12","key":"10.1016\/j.ygyno.2011.07.097_bb0055","first-page":"40","article-title":"Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III\/IV ovarian cancer","volume":"23","author":"McGuire","year":"1996","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.07.097_bb0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/10428190701769657","article-title":"Influence of DNA damage and repair upon the risk of treatment related leukemia","volume":"49","author":"Guillem","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"3 Suppl. 7","key":"10.1016\/j.ygyno.2011.07.097_bb0065","first-page":"3","article-title":"Paclitaxel\/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer","volume":"27","author":"Ozols","year":"2000","journal-title":"Semin Oncol"},{"issue":"25","key":"10.1016\/j.ygyno.2011.07.097_bb0070","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1182\/blood-2010-01-234120","article-title":"G-CSF and its receptor in myeloid malignancy","volume":"115","author":"Beekman","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ygyno.2011.07.097_bb0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jnci\/djk028","article-title":"Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony stimulating factors during breast cancer adjuvant chemotherapy","volume":"99","author":"Hershman","year":"2007","journal-title":"J Natl Cancer Inst"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811006718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811006718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T11:51:46Z","timestamp":1543578706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811006718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0090825811006718"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.097","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}